The Treating To Target in Type 2 diabetes (4-T) study is a three-year, multi-centre, open-label, randomised, parallel-group trial comparing the safety and efficacy of three different analogue insulin treatment regimens in 700 participants with Type 2 diabetes inadequately controlled by oral therapy.
- Principal Investigator: Professor Rury Holman
- Co-Investigators: Dr Jonathan Levy, Dr Andrew Farmer and Professor Melanie Davies
- Trial Manager: Julie Darbyshire
- Trial Administrator: Rachel Roberts
- ISRCTN number: 51125379
Latest News
| 2009 | October | 4-T final results published |
4-T Office, Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857239 Fax: +44 (0)1865 857248 Email: 4-T@dtu.ox.ac.uk
Home | Contact | Map | Freedom of Information | Privacy Policy | Copyright | Accessibility | OCDEM | NDM | Oxford University